Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.
All content for PayerTalkCE is the property of IMPACT and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.
PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on COPD
PayerTalkCE
55 minutes 34 seconds
6 months ago
PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on COPD
This podcast features expert discussion on the emerging role of type 2 (T2) inflammation in chronic obstructive pulmonary disease (COPD) and the implications for payer and provider decision-making. Faculty review key pathophysiologic mechanisms and biomarkers—particularly eosinophil counts—that identify patients most likely to benefit from targeted biologic therapies. The conversation also explores updated GOLD guideline recommendations, strategies to optimize formulary access, the impact of T2 inflammation on long-term outcomes, and opportunities to reduce hospitalizations and oral steroid use. Health plan professionals will gain insights into aligning policies with evolving clinical evidence and enhancing care coordination to improve outcomes.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/type2-inflammation-copd-management/.
PayerTalkCE
Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.
